LEI 5299006W7V4L6SO8JA54
Nuvisan ICB GmbH
Contract awards & public grants
Harnessing biobanking, Organ models, and Patient Empowerment for a better quality of life for women living within Polyendocrine Metabolic Ovary Syndro → NUVISAN ICB GMBH
European Commission · DE · Grant · 2026-07-24
€974,680
Protein-ligand data generation at scale to support computational hit finding and optimization → NUVISAN ICB GMBH
European Commission · DE · Grant · 2025-12-17
—
101252959 - LIGAND-AI - PROTEIN-LIGAND DATA GENERATION AT SCALE TO SUPPORT COMPUTATIONAL HIT FINDING AND OPTIMIZATION → NUVISAN ICB GMBH
IMI - Innov.Health Initiative · DE · Grant · 2025-11-01
€29.9M
Closing the loop in stereoselective catalysis with data-driven approaches → NUVISAN ICB GMBH
European Commission · DE · Grant · 2024-07-05
—
Developing broad-spectrum antiviral drugs for pandemic preparedness → NUVISAN ICB GMBH
European Commission · DE · Grant · 2023-12-11
—
THERAPEUTIC EPIGENETIC ENHANCEMENT OF THE INNATE IMMUNITY TO EFFECTIVELY COMBAT ANTIMICROBIAL RESISTANCE [IN-ARMOR] → NUVISAN ICB GMBH
European Commission · DE · Grant · 2023-03-15
—
Corona Accelerated R&D in Europe → NUVISAN ICB GMBH
European Commission · DE · Grant · 2020-08-07
€1.7M
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.